NJ Victories For Novartis To Curb Zometa Pile-On Suits
A New Jersey appellate decision Friday refusing to revive a mass tort lawsuit against Novartis Pharmaceuticals Corp. over its bone medication Zometa should give businesses even more certainty on statute of...To view the full article, register now.
Already a subscriber? Click here to view full article